✦ LIBER ✦

High complete remission rate and durable remissions achieved with rational use of autologous stem-cell transplantation, thalidomide maintenance, and non-myeloablative allogeneic transplantation in patients with multiple myeloma

✍ Scribed by Basak Oyan; Yener Koc; Evren Ozdemir; Ayse Kars; Alev Turker; Gulten Tekuzman; Emin Kansu

Book ID: 110890093
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 269 KB
Volume: 23
Category: Article
ISSN: 0902-0063
DOI: 10.1111/j.1399-0012.2008.00950.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-dose therapy/autologous stem cell t

High-dose therapy/autologous stem cell transplantation in patients with chemosensitive multiple myeloma: predictors of complete remission

✍ Nadal, E; Giné, E; Bladé, J; Esteve, J; Rosiñol, L; Fernández-Avilés, F; Marin, 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 127 KB

Complete remission after myeloablation w

Complete remission after myeloablation with bone-seeking 186Re-HEDP and high-dose melphalan followed by autologous stem cell transplantation in a patient with chemorefractory multiple myeloma

✍ Wiesmann, A; Einsele, H; Kanz, L; Dohmen, B M 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 87 KB

High-dose therapy and autologous periphe

High-dose therapy and autologous peripheral blood stem cells transplantation followed by a very low reduced intensity regimen with fludarabine + cyclophosphamide and allograft improve complete remission rate in de novo multiple myeloma patients

✍ Massimo Martino; Giuseppe Console; Giuseppe Irrera; Giulia Praticò; Caterina Ste 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 240 KB 👁 2 views

## Abstract The recent development of reduced intensity conditioning and allotransplantation (RICT) has opened a new way to assure engraftment of donor cells while reducing early transplant‐related mortality. We evaluated the combination of high‐dose therapy and autologous peripheral blood stem cel

High Rates of Non-Relapse Mortality and

High Rates of Non-Relapse Mortality and Graft-Versus-Host Disease in Patient Undergoing Allogeneic Stem Cell Transplantation (ASCT) Following Non-Myeloablative (NMA) Conditioning With TLI/ATG

✍ A.S. Kanate; L. Chaudhary; A. Cumpston; S. Leadmon; P. Bunner; D. Bulian; L. Gib 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 60 KB

18: Autologous peripheral blood stem cel

18: Autologous peripheral blood stem cell transplant using busulfan, etoposide, high dose Ara-C, and G-CSF priming as conditioning regimen in patients with acute myeloid leukemia in first complete remission

✍ F. Moscardó; J. Dı́az Mediavilla; J. de la Rubia; P. Fernández; C. Rayón; G. Cañ 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Prognostic Factors and Clinical Outcomes

Prognostic Factors and Clinical Outcomes of High-Dose Chemotherapy followed by Autologous Stem Cell Transplantation in Patients with Peripheral T Cell Lymphoma, Unspecified: Complete Remission at Transplantation and the Prognostic Index of Peripheral T Cell Lymphoma Are the Major Factors Predictive of Outcome

✍ Deok-Hwan Yang; Won Seog Kim; Seok Jin Kim; Sung Hwa Bae; Sung Hyun Kim; In Ho K 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 360 KB